Review



spinning-disk microscope inverted eclipse ti-2  (Nikon)


Bioz Verified Symbol Nikon is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Nikon spinning-disk microscope inverted eclipse ti-2
    Spinning Disk Microscope Inverted Eclipse Ti 2, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pm39729986-312-6-11?v=Nikon
    Average 90 stars, based on 1 article reviews
    spinning-disk microscope inverted eclipse ti-2 - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    90
    Nikon spinning-disk microscope inverted eclipse ti-2
    Spinning Disk Microscope Inverted Eclipse Ti 2, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pm39729986-312-6-11?v=Nikon
    Average 90 stars, based on 1 article reviews
    spinning-disk microscope inverted eclipse ti-2 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    99
    Nikon ti 2 spinning disk inverted microscope
    Ti 2 Spinning Disk Inverted Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pm38964322-1052-19-18?v=Nikon
    Average 99 stars, based on 1 article reviews
    ti 2 spinning disk inverted microscope - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Nikon ti 2 eclipse inverted spinning disk confocal microscope
    Ti 2 Eclipse Inverted Spinning Disk Confocal Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/10__1091_slash_mbc__e23___11___0419-153-6-5?v=Nikon
    Average 99 stars, based on 1 article reviews
    ti 2 eclipse inverted spinning disk confocal microscope - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    90
    Nikon brightfield microscopy nikon spinning disk ti 2 eclipse inverted confocal microscope
    Effect of drug alone on organoid growth and viability. ( a ) <t>Brightfield</t> images and quantification of organoid area using cultures treated with Nivolumab, Mubritinib and Cabozantinib alone. ( b ) Brightfield images and quantification of organoid area using organoid/CTL/MDSC co-cultures treated with Cabozantinib alone, Nivolumab plus Cabozantinib, or Mubritinib plus Cabozantinib. * p < 0.05 compared to Cabozantinib alone. Scale bar = 100 μm.
    Brightfield Microscopy Nikon Spinning Disk Ti 2 Eclipse Inverted Confocal Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pmc08699100-89-11-13?v=Nikon
    Average 90 stars, based on 1 article reviews
    brightfield microscopy nikon spinning disk ti 2 eclipse inverted confocal microscope - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Nikon inverted confocal spinning-disk microscope nikon eclipse ti-2
    Effect of drug alone on organoid growth and viability. ( a ) <t>Brightfield</t> images and quantification of organoid area using cultures treated with Nivolumab, Mubritinib and Cabozantinib alone. ( b ) Brightfield images and quantification of organoid area using organoid/CTL/MDSC co-cultures treated with Cabozantinib alone, Nivolumab plus Cabozantinib, or Mubritinib plus Cabozantinib. * p < 0.05 compared to Cabozantinib alone. Scale bar = 100 μm.
    Inverted Confocal Spinning Disk Microscope Nikon Eclipse Ti 2, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pmc08657697-265-6-9?v=Nikon
    Average 90 stars, based on 1 article reviews
    inverted confocal spinning-disk microscope nikon eclipse ti-2 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Nikon 100x oil-immersion objective equipped nikon eclipse ti-2 inverted spinning disk confocal microscope
    Effect of drug alone on organoid growth and viability. ( a ) <t>Brightfield</t> images and quantification of organoid area using cultures treated with Nivolumab, Mubritinib and Cabozantinib alone. ( b ) Brightfield images and quantification of organoid area using organoid/CTL/MDSC co-cultures treated with Cabozantinib alone, Nivolumab plus Cabozantinib, or Mubritinib plus Cabozantinib. * p < 0.05 compared to Cabozantinib alone. Scale bar = 100 μm.
    100x Oil Immersion Objective Equipped Nikon Eclipse Ti 2 Inverted Spinning Disk Confocal Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ti+2+spinning+disk+inverted+microscope/pmc06286407-445-15-11?v=Nikon
    Average 90 stars, based on 1 article reviews
    100x oil-immersion objective equipped nikon eclipse ti-2 inverted spinning disk confocal microscope - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Effect of drug alone on organoid growth and viability. ( a ) Brightfield images and quantification of organoid area using cultures treated with Nivolumab, Mubritinib and Cabozantinib alone. ( b ) Brightfield images and quantification of organoid area using organoid/CTL/MDSC co-cultures treated with Cabozantinib alone, Nivolumab plus Cabozantinib, or Mubritinib plus Cabozantinib. * p < 0.05 compared to Cabozantinib alone. Scale bar = 100 μm.

    Journal: Cancers

    Article Title: Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids

    doi: 10.3390/cancers13246158

    Figure Lengend Snippet: Effect of drug alone on organoid growth and viability. ( a ) Brightfield images and quantification of organoid area using cultures treated with Nivolumab, Mubritinib and Cabozantinib alone. ( b ) Brightfield images and quantification of organoid area using organoid/CTL/MDSC co-cultures treated with Cabozantinib alone, Nivolumab plus Cabozantinib, or Mubritinib plus Cabozantinib. * p < 0.05 compared to Cabozantinib alone. Scale bar = 100 μm.

    Article Snippet: Organoid-immune cell co-cultures were treated for 48 h and observed using brightfield microscopy (Nikon Spinning disk Ti 2 Eclipse inverted confocal microscope, Nikon Corporation, Tokyo, Japan).

    Techniques:

    HER2 expression is significantly correlated with PD-L1 expression in gastric cancer tissues. Brightfield images showing morphological differences among huTGOs derived from intestinal ( a , e ) and diffuse ( i , m ) subtypes of gastric cancer tissues. Immunofluorescence staining of these organoids showed a high expression of ( b – d , j – l ) HER2 (red) and PD-L1 (green) in two of the organoid lines while others showed a negative expression ( f – h , n – p ) for both. Western blot ( v ) analysis of gastric cancer tissues showed a similar expression pattern. ( q ) shRNA knockdown of HER2 showed a downregulation of PD-L1 expression which was confirmed by ( u ) Western blot analysis and quantification. ( r , s ) Quantification of HER2 and PD-L1 positive cells showed a significant reduction in the expression of both genes after HER2 shRNA knockdown; * p < 0.0001. ( t ) Linear regression analysis showing a positive correlation of HER2 and PD-L1; Immunohistochemistry of PD-L1 ( w ) and HER2 ( x ) retained high expression levels among gastric cancer tissues, tissue-derived organoids and orthotopically transplanted organoids. Scale bar = 100 μm and 50 μm.

    Journal: Cancers

    Article Title: Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids

    doi: 10.3390/cancers13246158

    Figure Lengend Snippet: HER2 expression is significantly correlated with PD-L1 expression in gastric cancer tissues. Brightfield images showing morphological differences among huTGOs derived from intestinal ( a , e ) and diffuse ( i , m ) subtypes of gastric cancer tissues. Immunofluorescence staining of these organoids showed a high expression of ( b – d , j – l ) HER2 (red) and PD-L1 (green) in two of the organoid lines while others showed a negative expression ( f – h , n – p ) for both. Western blot ( v ) analysis of gastric cancer tissues showed a similar expression pattern. ( q ) shRNA knockdown of HER2 showed a downregulation of PD-L1 expression which was confirmed by ( u ) Western blot analysis and quantification. ( r , s ) Quantification of HER2 and PD-L1 positive cells showed a significant reduction in the expression of both genes after HER2 shRNA knockdown; * p < 0.0001. ( t ) Linear regression analysis showing a positive correlation of HER2 and PD-L1; Immunohistochemistry of PD-L1 ( w ) and HER2 ( x ) retained high expression levels among gastric cancer tissues, tissue-derived organoids and orthotopically transplanted organoids. Scale bar = 100 μm and 50 μm.

    Article Snippet: Organoid-immune cell co-cultures were treated for 48 h and observed using brightfield microscopy (Nikon Spinning disk Ti 2 Eclipse inverted confocal microscope, Nikon Corporation, Tokyo, Japan).

    Techniques: Expressing, Derivative Assay, Immunofluorescence, Staining, Western Blot, shRNA, Knockdown, Immunohistochemistry

    Inhibition of HER2 regulates PD-L1 expression by suppressing HER2/AKT/MTOR signaling in gastric cancer-derived organoids. The expression of the HER2/AKT/MTOR signaling pathway components were determined by ( a ) Western blot analysis. ( b ) Violin plots representing densitometric values of protein bands measured from 8a. Brightfield images and the calculated organoid area in cultures treated with ( c ) vehicle (control), or ( d ) Everolimus. n = 15 ROI from 3 different experiments, * p < 0.05 in comparison to vehicle. Immunofluorescences staining using antibodies specific for HER2 (green) and PD-L1 (red) using ( e ) vehicle (control), or ( f ) Everolimus treated organoid cultures. ( g ) Quantification of fluorescence intensity for PD-L1 expression in the control or Everolimus treated cultures. ( h ) Proposed mechanisms of anti-PD1 inhibition and suppression of MDSCs in a combination immunotherapy strategy for gastric cancer patients. Within the gastric TME, PMN-MDSCs override the checkpoint inhibition by releasing Arg1, iNOS and ROS. Pharmacological inhibition of ERBB2/HER2 could diminish PD-L1 +ve cells from the TME, improving patient responses to immunotherapy. Scale bar = 100 μm.

    Journal: Cancers

    Article Title: Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids

    doi: 10.3390/cancers13246158

    Figure Lengend Snippet: Inhibition of HER2 regulates PD-L1 expression by suppressing HER2/AKT/MTOR signaling in gastric cancer-derived organoids. The expression of the HER2/AKT/MTOR signaling pathway components were determined by ( a ) Western blot analysis. ( b ) Violin plots representing densitometric values of protein bands measured from 8a. Brightfield images and the calculated organoid area in cultures treated with ( c ) vehicle (control), or ( d ) Everolimus. n = 15 ROI from 3 different experiments, * p < 0.05 in comparison to vehicle. Immunofluorescences staining using antibodies specific for HER2 (green) and PD-L1 (red) using ( e ) vehicle (control), or ( f ) Everolimus treated organoid cultures. ( g ) Quantification of fluorescence intensity for PD-L1 expression in the control or Everolimus treated cultures. ( h ) Proposed mechanisms of anti-PD1 inhibition and suppression of MDSCs in a combination immunotherapy strategy for gastric cancer patients. Within the gastric TME, PMN-MDSCs override the checkpoint inhibition by releasing Arg1, iNOS and ROS. Pharmacological inhibition of ERBB2/HER2 could diminish PD-L1 +ve cells from the TME, improving patient responses to immunotherapy. Scale bar = 100 μm.

    Article Snippet: Organoid-immune cell co-cultures were treated for 48 h and observed using brightfield microscopy (Nikon Spinning disk Ti 2 Eclipse inverted confocal microscope, Nikon Corporation, Tokyo, Japan).

    Techniques: Inhibition, Expressing, Derivative Assay, Western Blot, Control, Comparison, Staining, Fluorescence